These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19230674)

  • 1. Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
    Aresté C; Blackbourn DJ
    Trends Microbiol; 2009 Mar; 17(3):119-29. PubMed ID: 19230674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular virology of Kaposi's sarcoma-associated herpesvirus.
    Moore PS; Chang Y
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):499-516. PubMed ID: 11313008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Cesarman E; Knowles DM
    Semin Diagn Pathol; 1997 Feb; 14(1):54-66. PubMed ID: 9044510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8).
    Damania B
    Cell Biochem Biophys; 2004; 40(3):305-22. PubMed ID: 15211030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus.
    Cathomas G
    Herpes; 2003 Dec; 10(3):72-7. PubMed ID: 14759339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
    Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
    J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
    Schulz TF
    J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus (KSHV/HHV8): key aspects of epidemiology and pathogenesis.
    Viejo-Borbolla A; Schulz TF
    AIDS Rev; 2003; 5(4):222-9. PubMed ID: 15012001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
    Engels EA; Pittaluga S; Whitby D; Rabkin C; Aoki Y; Jaffe ES; Goedert JJ
    Mod Pathol; 2003 May; 16(5):424-9. PubMed ID: 12748248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.
    Rezaee SAR; Cunningham C; Davison AJ; Blackbourn DJ
    J Gen Virol; 2006 Jul; 87(Pt 7):1781-1804. PubMed ID: 16760382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis.
    Sharp TV; Boshoff C
    IUBMB Life; 2000 Feb; 49(2):97-104. PubMed ID: 10776590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus.
    Means RE; Choi JK; Nakamura H; Chung YH; Ishido S; Jung JU
    Curr Top Microbiol Immunol; 2002; 269():187-201. PubMed ID: 12224509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
    Conrad NK
    Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kaposi's sarcoma-associated herpesvirus (KSHV): a new viral pathogen associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Said J
    West J Med; 1997 Jul; 167(1):37-8. PubMed ID: 9265864
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune evasion by Kaposi's sarcoma-associated herpesvirus.
    Coscoy L
    Nat Rev Immunol; 2007 May; 7(5):391-401. PubMed ID: 17457345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.
    Jenner RG; Albà MM; Boshoff C; Kellam P
    J Virol; 2001 Jan; 75(2):891-902. PubMed ID: 11134302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.